Doximity, Inc. (NASDAQ:DOCS) Position Cut by Legal & General Group Plc

Legal & General Group Plc cut its holdings in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 3.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 185,695 shares of the company's stock after selling 6,465 shares during the period. Legal & General Group Plc owned about 0.10% of Doximity worth $9,914,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Global Retirement Partners LLC boosted its position in Doximity by 468.1% during the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after acquiring an additional 440 shares during the last quarter. UMB Bank n.a. lifted its position in Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company's stock worth $31,000 after buying an additional 235 shares during the period. Larson Financial Group LLC boosted its stake in Doximity by 49.4% in the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after buying an additional 250 shares during the last quarter. Optimum Investment Advisors purchased a new stake in Doximity in the 4th quarter valued at about $43,000. Finally, Morse Asset Management Inc purchased a new position in shares of Doximity during the 3rd quarter worth about $46,000. 87.19% of the stock is owned by institutional investors and hedge funds.

Doximity Trading Up 6.2 %

DOCS stock traded up $3.23 during mid-day trading on Wednesday, hitting $55.63. 696,579 shares of the company were exchanged, compared to its average volume of 1,981,810. The company has a market capitalization of $10.39 billion, a PE ratio of 55.63, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41. The firm has a fifty day simple moving average of $62.00 and a 200 day simple moving average of $55.94. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $85.21.

Insider Buying and Selling

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the transaction, the director now owns 6,360 shares of the company's stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 37.40% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on DOCS shares. Mizuho upped their price target on shares of Doximity from $55.00 to $65.00 and gave the stock a "neutral" rating in a research report on Monday, February 10th. Wells Fargo & Company reiterated an "equal weight" rating on shares of Doximity in a report on Friday, February 7th. KeyCorp reduced their price objective on Doximity from $83.00 to $70.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Leerink Partnrs raised shares of Doximity from a "hold" rating to a "strong-buy" rating in a research report on Friday, February 7th. Finally, Piper Sandler raised shares of Doximity from a "neutral" rating to an "overweight" rating and increased their price objective for the stock from $31.00 to $78.00 in a research report on Friday, February 7th. Eleven research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $65.00.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.